A study by an international group of researchers finds popular diabetes and weight-loss drugs are not linked to pregnancy ...

A new framework which categorises the outcomes of type 2 diabetes could be instrumental in the drive to alter the progression ...

New real-world data to be presented at EASD 2026 suggest continuous glucose monitoring could have benefits extending beyond ...

Debbie Hicks is stepping down as Chair of Trend Diabetes after almost two decades with the organisation, as she prepares to ...

Four technology appraisals for type 2 diabetes have been updated, and guidance on 4 further medicines is being withdrawn, as part of NICE’s first test of a new way of keeping all its guidance aligned.

The Cambridge Diabetes Education Programme (CDEP) has launched a new competency-based training topic to give hospital trusts ...

Healthcare professionals are being offered new educational support to help recognise chronic kidney disease (CKD) earlier and ...

We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference. The sponsoring companies are Abbott, ...

A nationwide study being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has found that people with type 2 diabetes have ...

People using Roche’s Accu-Chek SmartGuide continuous glucose monitoring (CGM) system will begin transitioning to the mySugr app from July 7, bringing glucose data, predictive insights and diabetes ...

A major international trial is recruiting people with type 1 diabetes to investigate whether diabetes technology, psychoeducation or a combination of the two is most effective at restoring impaired ...

Abbott has secured a CE Mark for the world’s first dual glucose‑ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day, the systems are designed to continuously ...